Table 3 Comparisons of the Change in MBR and Clinical Characteristics.

Age, years

54.2 ± 7.0

62.1 ± 14.8

0.12^a

Male, eyes (%)

15 (83.8)

8 (72.7)

0.41^b

LogMAR BCVA at baseline

0.18 ± 0.24

0.17 ± 0.13

0.49^c

AL, mm

24.2 ± 0.8

24.3 ± 1.5

0.73^a

Smoking status, Never/past/current smokers, eyes

0/9/9

6/4/1

 < 0.001^b

CCT at baseline, μm

422.2 ± 105.4

300.4 ± 77.6

0.003^a

CCT change at one month, %

82.1 ± 13.7

71.0 ± 19.8

0.085^a

MBR at baseline, AU

10.1 ± 3.5

9.0 ± 2.8

0.41^a

GLD of half-dose PDT, μm

4356.8 ± 816.0

4391.5 ± 920.9

0.92^a

Duration from onset to PDT

9.5 ± 7.7

30.5 ± 70.9

0.25^c